Tipranavir (TPV)

DRUG4 trials

Sponsors

Boehringer Ingelheim

Conditions

HIV InfectionsHealthyHepatic Insufficiency

Phase 1

Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult Volunteers

CompletedNCT02195466

Boehringer IngelheimHealthy

Start: 2003-06-30Updated: 2014-07-21

Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency

CompletedNCT02249442

Boehringer IngelheimHepatic Insufficiency

Start: 2003-10-01Updated: 2025-01-23

Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers

CompletedNCT02253875

Boehringer IngelheimHealthy

Start: 2005-11-30Updated: 2014-10-01

Phase 2

Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir

CompletedNCT02249130

Boehringer IngelheimHIV Infections

Start: 1999-03-31Updated: 2014-09-25